Olivia holds the William R Lindsay Chair of Health Economics at Health Economics and Health Technology Assessment (HEHTA), University of Glasgow and is Adjunct Professor at the Faculty of Pharmacy, Mahidol University in Thailand. She is also an elected Fellow of the Royal Society of Edinburgh. Olivia has expertise in a broad range of health technology assessment (HTA) methodologies and is interested in adapting and applying HTA methodologies in context. Her research is multidisciplinary in nature, and spans across a wide range of clinical areas and different types of health interventions (e.g. pharmacological treatments, medical devices, diagnostic tests, and digital health interventions). She has led numerous health economic evaluations alongside clinical evaluations and trials, which work has informed clinical guidelines and health policy decisions, both at national and international levels. Olivia also has a body of work on novel and effective use of evidence synthesis approaches to maximise the value of existing data for informing clinical and economic evaluations. Currently, Olivia leads the Complex Reviews Synthesis Unit (CRSU) which hosts one of the nine Evidence Synthesis Groups funded by the National Institute for Health and Care Research (NIHR).
Olivia collaborates widely and is chief and co-investigator of active research projects with a cumulative value of over £50 million. In addition to her research, Olivia is a long-standing advisor to HTA agencies within and out with the UK. She has previously served as member of the NICE Technology Appraisal Committee for 10 years. Currently, Olivia is the Director of two NIHR Research Programmes – Better Methods Metter Research (BMBR) and the National Research Collaboration Programme (NRCP). Most recently, she has also been appointed Chair of REF2029 Sub-panel 2: Public Health, Health Services and Primary Care.
